Dec 10 (Reuters) - CervoMed ( CRVO ) said on Tuesday
that its experimental drug for a form of dementia did not meet
the main or secondary goals in mid-stage clinical trial.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Anil
D'Silva)